ATE495443T1 - Reduzierung des risikos für komplikationen bei frühgeburten - Google Patents
Reduzierung des risikos für komplikationen bei frühgeburtenInfo
- Publication number
- ATE495443T1 ATE495443T1 AT01987331T AT01987331T ATE495443T1 AT E495443 T1 ATE495443 T1 AT E495443T1 AT 01987331 T AT01987331 T AT 01987331T AT 01987331 T AT01987331 T AT 01987331T AT E495443 T1 ATE495443 T1 AT E495443T1
- Authority
- AT
- Austria
- Prior art keywords
- igf
- binding protein
- risk
- patient
- preterm birth
- Prior art date
Links
- 208000005107 Premature Birth Diseases 0.000 title abstract 5
- 206010036590 Premature baby Diseases 0.000 title 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 abstract 11
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 abstract 11
- 238000000034 method Methods 0.000 abstract 3
- 210000004291 uterus Anatomy 0.000 abstract 3
- 206010012559 Developmental delay Diseases 0.000 abstract 1
- 206010022840 Intraventricular haemorrhage Diseases 0.000 abstract 1
- 208000036626 Mental retardation Diseases 0.000 abstract 1
- 206010038933 Retinopathy of prematurity Diseases 0.000 abstract 1
- 206010006475 bronchopulmonary dysplasia Diseases 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 230000036266 weeks of gestation Effects 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4745—Insulin-like growth factor binding protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Reproductive Health (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Obesity (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cardiology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0004405A SE0004405D0 (sv) | 2000-11-28 | 2000-11-28 | New composition and use |
US27425201P | 2001-03-09 | 2001-03-09 | |
PCT/US2001/047285 WO2002043578A2 (en) | 2000-11-28 | 2001-11-13 | Determination of risk and treatment of complications of prematurity |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE495443T1 true ATE495443T1 (de) | 2011-01-15 |
Family
ID=26655321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01987331T ATE495443T1 (de) | 2000-11-28 | 2001-11-13 | Reduzierung des risikos für komplikationen bei frühgeburten |
Country Status (9)
Country | Link |
---|---|
US (2) | US7144707B2 (de) |
EP (1) | EP1402266B1 (de) |
JP (2) | JP4173732B2 (de) |
AT (1) | ATE495443T1 (de) |
AU (2) | AU3956002A (de) |
CA (1) | CA2429615C (de) |
CY (1) | CY1111213T1 (de) |
DE (1) | DE60143858D1 (de) |
WO (1) | WO2002043578A2 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003012043A2 (en) * | 2001-07-27 | 2003-02-13 | Hanauske-Abel Hartmut M | Enhancing organ maturity in neonates and predicting their duration of intensive care |
PL2083863T3 (pl) * | 2006-10-03 | 2015-08-31 | Genzyme Corp | Przeciwciała przeciwko TGF-beta do stosowania w leczeniu niemowląt obarczonych ryzykiem rozwinięcia się dysplazji oskrzelowo-płucnej |
WO2008130315A1 (en) | 2007-04-18 | 2008-10-30 | Premacure Ab | Method and product for treatment and/or prevention of complications of prematurity |
CA2698374C (en) | 2007-09-07 | 2018-04-03 | Children's Hospital Medical Center | Use of secretor, lewis and sialyl antigen levels as predictors for disease |
DK2217329T3 (en) * | 2007-11-07 | 2018-04-23 | Anthrogenesis Corp | APPLICATION OF NAVLINE BLOOD IN THE TREATMENT OF COMPLIANCES IN CONNECTION WITH PREGNANCY BIRTH |
JP5398054B2 (ja) * | 2008-08-20 | 2014-01-29 | 株式会社 資生堂 | 「シミ」の蓋然性の評価方法 |
CA2767043C (en) | 2009-07-06 | 2020-07-14 | Children's Hospital Medical Center | Inhibiting inflammation with milk oligosaccharides |
RU2445945C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
RU2445944C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
RU2445946C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
RU2445943C1 (ru) * | 2010-10-14 | 2012-03-27 | Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по высокотехнологичной медицинской помощи" | Способ фотодинамической терапии задней агрессивной ретинопатии недоношенных |
WO2014130789A1 (en) | 2013-02-21 | 2014-08-28 | Children's Hospital Medical Center | Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease |
RU2526827C1 (ru) * | 2013-05-23 | 2014-08-27 | Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития пороговой стадии ретинопатии недоношенных у детей без офтальмологических признаков заболевания |
JP5559406B2 (ja) * | 2013-09-11 | 2014-07-23 | 株式会社 資生堂 | シミを有する蓋然性を評価する方法 |
RU2536284C1 (ru) * | 2013-09-19 | 2014-12-20 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Российский национальный исследовательский медицинский университет им. Н.И. Пирогова Министерства здравоохранения Российской Федерации" (ГБОУ ВПО РНИМУ Минздрава России) | Способ оценки тяжести течения и возможного исхода ретинопатии у недоношенных детей |
US10857167B2 (en) | 2015-04-28 | 2020-12-08 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
RU2639134C2 (ru) * | 2016-01-21 | 2017-12-19 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития внутрижелудочковых кровоизлияний у новорожденных, родившихся после экстракорпорального оплодотворения |
CN111432881A (zh) * | 2017-09-11 | 2020-07-17 | 夏尔人类遗传性治疗公司 | 用于治疗慢性肺病的方法和组合物 |
RU2741727C1 (ru) * | 2020-07-06 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования развития внутрижелудочковых кровоизлияний у недоношенных новорожденных |
RU2741722C1 (ru) * | 2020-07-06 | 2021-01-28 | Федеральное государственное бюджетное учреждение "Ивановский научно-исследовательский институт материнства и детства имени В.Н. Городкова" Министерства здравоохранения Российской Федерации | Способ прогнозирования внутрижелудочковых кровоизлияний у недоношенных новорожденных |
EP3936054A1 (de) * | 2020-07-08 | 2022-01-12 | Assistance Publique - Hôpitaux de Paris | Verfahren zur prognose von bronchopulmonaler dysplasie bei frühgeborenen |
CN113528688A (zh) * | 2021-09-09 | 2021-10-22 | 北京泱深生物信息技术有限公司 | 微生物在制备用于诊断生长发育迟缓的产品中的应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5330971A (en) * | 1989-06-09 | 1994-07-19 | Gropep Pty. Ltd. | Growth hormone fusion proteins, methods of production, and methods of treatment |
SE9002731D0 (sv) * | 1990-08-24 | 1990-08-24 | Kabivitrum Ab | Product comprising growth factor |
ZA978334B (en) * | 1996-09-16 | 1999-03-16 | Univ Dalhousie | Use of IFG-I for the treatment of kidney disorders renal insufficiencies steriod toxicity and related indications |
US6121416A (en) * | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
WO2003012043A2 (en) | 2001-07-27 | 2003-02-13 | Hanauske-Abel Hartmut M | Enhancing organ maturity in neonates and predicting their duration of intensive care |
-
2001
- 2001-11-13 EP EP01987331A patent/EP1402266B1/de not_active Expired - Lifetime
- 2001-11-13 CA CA2429615A patent/CA2429615C/en not_active Expired - Lifetime
- 2001-11-13 WO PCT/US2001/047285 patent/WO2002043578A2/en active Search and Examination
- 2001-11-13 JP JP2002545565A patent/JP4173732B2/ja not_active Expired - Lifetime
- 2001-11-13 AU AU3956002A patent/AU3956002A/xx active Pending
- 2001-11-13 DE DE60143858T patent/DE60143858D1/de not_active Expired - Lifetime
- 2001-11-13 AU AU2002239560A patent/AU2002239560B2/en not_active Expired
- 2001-11-13 AT AT01987331T patent/ATE495443T1/de active
-
2003
- 2003-05-28 US US10/446,648 patent/US7144707B2/en not_active Expired - Lifetime
-
2006
- 2006-09-14 US US11/521,209 patent/US7776820B2/en not_active Expired - Lifetime
-
2008
- 2008-03-10 JP JP2008059153A patent/JP5089443B2/ja not_active Expired - Lifetime
-
2011
- 2011-02-22 CY CY20111100212T patent/CY1111213T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JP2008163043A (ja) | 2008-07-17 |
US20040053838A1 (en) | 2004-03-18 |
US20070196857A1 (en) | 2007-08-23 |
CY1111213T1 (el) | 2015-06-11 |
EP1402266A4 (de) | 2007-12-12 |
WO2002043578A3 (en) | 2003-12-31 |
US7144707B2 (en) | 2006-12-05 |
EP1402266A2 (de) | 2004-03-31 |
AU2002239560B2 (en) | 2006-03-02 |
EP1402266B1 (de) | 2011-01-12 |
JP4173732B2 (ja) | 2008-10-29 |
WO2002043578A2 (en) | 2002-06-06 |
US7776820B2 (en) | 2010-08-17 |
JP5089443B2 (ja) | 2012-12-05 |
AU3956002A (en) | 2002-06-11 |
CA2429615C (en) | 2016-07-12 |
JP2004528529A (ja) | 2004-09-16 |
CA2429615A1 (en) | 2002-06-06 |
DE60143858D1 (de) | 2011-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1111213T1 (el) | Ελαττωση του κινδυνου επιπλοκων πρωιμοτητας | |
Bacq et al. | Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls | |
Roberts et al. | Recent insights into the pathogenesis of pre-eclampsia | |
Schiff et al. | The importance of urinary protein excretion during conservative management of severe preeclampsia | |
Mercado et al. | Thyroid function in very preterm infants | |
Yamada et al. | Genetic factors in fetal growth restriction and miscarriage | |
Erdem et al. | The effect of maternal anemia and iron deficiency on fetal erythropoiesis: comparison between serum erythropoietin, hemoglobin and ferritin levels in mothers and newborns | |
POUTA et al. | Midtrimester N-terminal proatrial natriuretic peptide, free beta hCG, and alpha-fetoprotein in predicting preeclampsia | |
Tisi et al. | Total protein concentration in human amniotic fluid is negatively associated with infant birth weight | |
Karlberg et al. | Changes in the renin-angiotensin-aldosterone and kallikrein-kinin systems during normal and hypertensive pregnancy | |
Halliday | Elective delivery at “term”: implications for the newborn | |
Sannia et al. | S100B protein maternal and fetal bloodstreams gradient in healthy and small for gestational age pregnancies | |
Beratis et al. | Cord blood α-fetoprotein concentrations in term newborns of smoking mothers | |
Setia et al. | Increased insulin sensitivity in intrauterine growth retarded newborns–Do thyroid hormones play a role? | |
Xu et al. | Maternal menstrual history and small-for-gestational-age births in a population-based Chinese birth cohort | |
McGrath et al. | Corticotrophin-releasing hormone and parturition. | |
Taghavi et al. | Outcome of thyroid dysfunction in pregnancy in Mashhad, Iran | |
Senses et al. | Is there a relationship between cord blood pregnancy-associated plasma protein-A and birth weight and length? | |
Farman et al. | Present Perspectives of Hyperthyroidism during Pregnancy | |
Sanz et al. | First-Trimester Biochemical Screening For Low Birth Weight: Clinical Effectiveness of Low Pregnancy-Associated Plasma Protein-A and High Thyroid-Stimulating Hormone. | |
Hamed et al. | Evaluation of Changes in Renal Function of Pregnant Women with Preeclampsia in Al-Jabal Al-Akhdar | |
Pluta et al. | Macro-TSH—tips and tricks for gynecologists | |
Panigrahi et al. | Prevalence of Antiphospholipid Antibodies in Patients with Bad Obstetric History of unknown Etiology and Its Association with Clinical Parameters | |
Al-Malt et al. | Hypocalciuria can differentiate preeclampsia from chronic hypertension in the third trimester | |
Dash et al. | Autoimmune Basis of Sub Clinical Hypothyroidism in Pregnancy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1402266 Country of ref document: EP |